Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without Metformin.
Thanida TangjarusritaratornWatip TangjittipokinTada KunavisarutPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2021)
Metformin exposure was associated with a lower incidence of HCC in cirrhosis with T2DM patients and seemed to extend survival. Continuing metformin in patients with cirrhosis with T2DM should be considered if there was no contraindication.